Efficacy of Zemedy, a Mobile Digital Therapeutic for the Self-management of Irritable Bowel Syndrome: Crossover Randomized Controlled Trial.

JMIR Mhealth Uhealth · 2021 · PMC8176342 · PMID 33872182

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

only marginally significantno p-value reported

For the immediate treatment group, all of the outcome variables changed significantly from pretreatment to posttreatment with the exception of the DASS Depression subscale, which showed only marginally significant improvement ( Table 3 ).

also in 5,076 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.